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Recombinant human cytosolic sialidase (HsNEU2), ex-
pressed in Escherichia coli, was purified to homogene-
ity, and its substrate specificity was studied. HsNEU2
hydrolyzed 4-methylumbelliferyl -NeuAc, 233 sialyl-
lactose, glycoproteins (fetuin, -acid glycoprotein,
transferrin, and bovine submaxillary gland mucin), mi-
cellar gangliosides GD1a, GD1b, GT1b, and 233 para-
globoside, and vesicular GM3. 236 sialyllactose, colo-
minic acid, GM1 oligosaccharide, whereas micellar GM2
and GM1 were resistant. The optimal pH was 5.6, kinet-
ics Michaelis-Menten type, Vmax varying from 250 IU/mg
protein (GD1a) to 0.7 IU/mg protein (1-acid glycopro-
tein), and Km in the millimolar range. HsNEU2 was acti-
vated by detergents (Triton X-100) only with ganglio-
sidic substrates; the change of GM3 from vesicular to
mixed micellar aggregation led to a 8.5-fold Vmax in-
crease. HsNEU2 acted on gangliosides (GD1a, GM1, and
GM2) at nanomolar concentrations. With these disper-
sions (studied in detailed on GM1), where monomers are
bound to the tube wall or dilutedly associated (1:2000,
mol/mol) to Triton X-100 micelles, the Vmax values were
25 and 72 IU/mg protein, and Km was 10 and 15  10
9
M, respectively. Remarkably, GM1 and GM2 were recog-
nized only as monomers. HsNEU2 worked at pH 7.0 with
an efficiency (compared with that at pH 5.6) ranging
from 4% (on GD1a) to 64% (on 1-acid glycoprotein), from
7% (on GD1a) to 45% (on GM3) in the presence of Triton
X-100, and from 30 to 40% on GM1 monomeric dispersion.
These results show that HsNEU2 differentially recog-
nizes the type of sialosyl linkage, the aglycone part of
the substrate, and the supramolecular organization
(monomer/micelle/vesicle) of gangliosides. The last abil-
ity might be relevant in sialidase interactions with gan-
gliosides under physiological conditions.
Sialidases (N-acylneuraminosylglycohydrolases; EC 3.2.1.18)
constitute a group of enzymes that hydrolytically remove sialic
acid residues from sialoglycoconjugates. The wide occurrence of
these enzymes from viruses and bacteria to vertebrates (1)
highlights their importance in regulating the sialic acid content
and turnover of sialoglycoconjugates, molecules that are fun-
damental to several cellular processes (2). Due to their easier
availability, viral and bacterial sialidases have been exten-
sively studied at the molecular level, and the three-dimen-
sional structure of several of them has been established (3–5).
Despite an amino acid sequence homology of only 35%, viral
and bacterial sialidases share a similar molecular architecture
with the protein chains folded into six-sided -sheet barrels
and the active site constituted by almost the same amino acids
and organized in a similar manner (6).
The molecular features of mammalian sialidases, including
the human enzymes, remained long obscure, since factors like
subcellular localization (cytosol, plasma membrane, and lyso-
somes), low cellular content, and the labile nature of the puri-
fied enzymes prevented workers from obtaining sufficient
amounts of pure and active enzyme for detailed studies (7, 8).
Beginning in 1993, several mammalian sialidases started be-
ing cloned from the corresponding cDNAs, prompting a great
acceleration of the studies aimed at ascertaining their struc-
tural and kinetic properties (9, 10). Knowledge of the amino
acid sequences of these sialidases provided insight into the
following: (i) the differences between the lysosomal (NEU1)
(11–13), cytosolic (NEU2) (14, 15), and plasma membrane-
associated (NEU3) sialidases (16, 17), which are unequivocally
different enzymes, and (ii) the structural homologies indicating
that they belong, unequivocally too, to a unique family of pro-
teins. Of course, a great advance provided by expressing mam-
malian sialidases in suitable host cells was to obtain pure
proteins in adequate amounts and sufficient stability to per-
form systematic studies.
Issues concerning mammalian sialidases that still require
deeper understanding are their relationships with the putative
natural substrates, particularly sialoglycolipids (gangliosides)
and sialoglycoproteins and the conditions of their action under
physiological conditions, since most of them feature in vitro an
acidic optimal pH (1, 2, 18, 19). It is known that sialidases occur
cellularly at different sites (plasma membrane, lysosomes, and
cytosol), and sialoglycoconjugates occur primarily at the level of
the plasma and Golgi’s stack membranes (18, 19) or inside the
lysosomes, where their complete degradation occurs (2, 18).
Another possible difference can reside in the topology of mem-
brane location (sidedness) of sialidases and sialoglycoconju-
gates. It is also known that (some) gangliosides can be highly
enriched in lipid rafts on the plasma membrane together with
other lipid components and specialized proteins (20). These
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structures move within the fluid bilayer and may function as
mobile platforms able to transduce signals from the outside to
the interior of the cell (21). Of course, gangliosides are also
present in a much more “diluted” way in the areas of the
membrane surrounding rafts. Therefore, gangliosides occur as
“patched” or “dispersed” molecules (monomeric dispersions),
this constituting a further possible matter of differential rec-
ognition by sialidases. With regard to the physiological envi-
ronment, the only one having an acidic pH is the lysosomal
matrix, where the lysosomal sialidase works. However, both
the plasma membrane-bound and the cytosolic sialidases, be-
sides the lysosomal one, display an acidic pH optimum (1, 2).
On these premises and with the aim to provide a deeper insight
into sialidase action, we (i) purified to homogeneity the recom-
binant form of the human cytosolic sialidase NEU2 (HsNEU2),
produced by Escherichia coli cells, (ii) carried out a basic bio-
chemical characterization of the enzyme, (iii) studied the spec-
ificity of the enzyme action on different sialoglycoconjugates,
with particular attention to the ability of the enzyme to differ-
entially recognize the aggregated (micellar) form and mono-
meric dispersion of the ganglioside substrates, and (iv) verified
the ability of the enzyme to act at neutral pH.
EXPERIMENTAL PROCEDURES
Commercial chemicals were of the highest grade available. N-Acetyl-
D-neuraminic acid (NeuAc), 4-methylumbelliferyl -NeuAc (MU-
NeuAc),1 and 4-methylumbelliferone, the N-glycosylated glycoproteins
human fetuin, human 1-acid glycoprotein, human transferrin, and
O-glycosylated glycoprotein mucin from bovine submaxillary glands,
233 sialyllactose sodium salt (purity, better than 98%), 236 sia-
lyllactose (purity better than 98%), crystalline bovine serum albumin,
sialidases (from Arthrobacter ureafaciens, Salmonella typhimurium (re-
combinant), Vibrio cholerae, and Clostridium perfringens), Triton
X-100, CHAPS, octyl glucoside, and sodium deoxycholate were provided
by Sigma; [3H]borohydride (6500 Ci/mol1) was provided by Amersham
Biosciences; DEAE-Sephadex A-25 was from Amersham Biosciences;
Dowex 2  8 resin (200–400-mesh), prepared in acetate form (22), was
from Bio-Rad; cationic and anionic exchange columns (Mono S HR 5/5
and Mono Q HR5/5), glutathione (GSH) 4B-Sepharose, and thrombin
were from Amersham Biosciences; ultrafiltration apparatus Mod.52
and Diaflo membranes (cut-off 10 kDa) were from Amicon (Witten,
Germany); precoated silica gel high performance thin layer chromatog-
raphy (HPTLC) plates (Kiesel gel 60, 250-m thickness, 10  20 cm)
and precoated cellulose thin layer plates (cellulose: 100-m thickness,
10  20 cm) were from Merck; and water was doubly distilled in a glass
apparatus and used to prepare the different solutions. The oligosaccha-
ride from ganglioside GM1 was prepared according to Wiegandt and
Bucking (23). Standard molecular biology techniques were performed
as described by Sambrook and Russell (24). DNA restriction and mod-
ifying enzymes were from Roche Applied Science unless indicated
otherwise.
Expression and Purification of Recombinant HsNEU2
The entire coding region of HsNEU2 was obtained by PCR amplifi-
cation using the isolated genomic clone HG7 as template as previously
described (15). Briefly, the DNA sequence from the Met to the Gln in
position 67 (exon 1) was amplified using NEU2-Nt (5-CGTAGATCTAT-
GGCGTCCCTTCCTGTCCTG-3) with a 5-BamHI restriction site and
a 5-phosphorylated antisense primer (NEU2–67R; 5-CTGAACCTG-
GTGGGTGGGTGC-3). The DNA sequence from the Trp in position 68
to the stop codon (exon 2) was amplified using (NEU2-68F; 5-TG-
GCAAGCTCAGGAGGTGGTG-3) and NEU2-Ct (5-CATGAATCCT-
CACTGAGGCAGGTACTG-3) with a 5-EcoRI restriction site. The two
PCR products, obtained using cloned Pfu polymerase (Stratagene, La
Jolla, CA), were ligated using T4 ligase, and the resulting fragment was
subcloned into BamHI-EcoRI sites of pGEX-2T expression vector (Am-
ersham Biosciences). The recombinant plasmid, pGEX-2T-NEU2, was
completely sequenced using both vector- and gene-specific primers.
E. coli DH5  cells were transformed with the recombinant plasmid
pGEX-2T-NEU2 or the expression vector pGEX-2T alone, and the
transformed cells were grown in LB-ampicillin medium at 37 °C to
midlog phase before the addition of isopropyl--D-thiogalactopyranoside
(Sigma) to 0.05 mM. After overnight growth at room temperature, cells
were harvested by centrifugation and suspended in 50 volumes of
phosphate-buffered saline (PBS). Cells lysed by sonication and super-
natants obtained after centrifugation at 12,000  g for 10 min were
assayed for sialidase activity using MU-NeuAc as substrate. Purifica-
tion of glutathione S-transferase (GST)-HsNEU2 fusion protein was
carried out by affinity chromatography on a GSH-Sepharose 4B column
(using the GST portion of the chimeric protein for affinity binding)
according to the manufacturer’s instructions (GST Gene Fusion Sys-
tem; Amersham Biosciences), with minor modifications. After an addi-
tional washing with PBS plus 0.5 M NaCl, cleavage of GST from the
GST-HsNEU2 fusion protein bound to the matrix was carried out
adding 0.5 IU of thrombin/ml in PBS and incubating the column for 2–3
h at room temperature. The resulting eluted enzyme was further puri-
fied by two successive high performance chromatographic steps. The
first was on a MONO Q HR5/5 column equilibrated with 20 mM Tris/
HCl, pH 7.3. The enzyme activity was eluted in the column flow-
through and the collected fractions carrying the enzyme were dialyzed
against four changes of 50 volumes of 50 mM MES buffer, pH 6.7, at
4 °C, concentrated under vacuum to about 2 ml in a rotating evaporator
and applied to a MONO S HR 5/5 column equilibrated in the same
buffer. The enzyme was eluted using a linear gradient of 50 mM MES
buffer, pH 6.7, containing 1 M NaCl. The two chromatographic steps
were carried out at room temperature with an elution rate of 1 ml/min
and using an FPLC apparatus (Amersham Biosciences). Protein sam-
ples of E. coli crude lysate and of the different fractions obtained along
the purification procedure were assayed for sialidase activity and pro-
tein content and monitored for purity by reducing SDS-PAGE (25) with
GELCODE Blue Stain protein detection reagent (Pierce). The purity of
the final enzyme preparation was assessed also by isoelectrofocusing
according to Righetti (26).
Preparation of Cold and 3H-Labeled Gangliosides and
Neutral Glycolipids
Gangliosides GM1, GM2, GD1a, and GD1b from calf brain (27), GM3
(carrying NeuAc) from human spleen (28), and 233 sialosylparaglo-
boside (233SPG) from human erythrocytes (29) were prepared and
structurally analyzed as previously described (30). Asialo-GM1 (GA1)
was prepared according to Ghidoni et al. (31). GM1, GM2, and GD1a
were 3H-labeled at C-3 of the sphingosine (Sph) moiety (32), and the
erythro forms, separated and purified (33), were employed. GM3 was
3H-labeled at the level of the N-acetyl group of sialic acid ([NeuAc-
3H]GM3) according to Chigorno et al. (34). GA1 3H-radiolabeled at the
level of Sph was prepared according to Ref. 35. The radiochemical
purity of [Sph-3H]GM1, [Sph-3H]GM2, [Sph-3H]GD1a, [NeuAc-
3H]GM3, and [Sph-3H]GA1 was better than 99%, and the specific ra-
dioactivity was 1.63, 0.96, 1.85, 0.60, and 1.58 Ci mmol1, respectively.
Radiolabeled gangliosides were stored at 20 °C in n-propyl alcohol/
water (4:1, v/v), and maintenance of radiochemical purity was assessed
before use.
Preparation of Homogeneous Micelles (or Vesicles) of Gangliosides
or of Mixed Micelles of Gangliosides and Detergents
It is known that gangliosides form micelles in water solution. Their
critical micellar concentration (CMC) is in the range 108 to 107 M,
depending on the ganglioside (36). Therefore, at concentrations above
the CMC (e.g. in the millimolar range), they are present essentially as
micelles, whereas below the CMC (e.g. in the nanomolar range) they are
present only as monomers. The only exception is ganglioside GM3 that
undergoes vesicular aggregation in aqueous solution (36). Homogenous
micelles of gangliosides 233SPG, GM1, GM2, GD1a, GD1b, and GT1b
and homogenous vesicles of GM3 (with the addition of 0.15 Ci of the
3H-labeled form in the cases of GM1, GM2, GD1a, and GM3) were
prepared as follows. Each ganglioside was dissolved in chloroform/
1 The abbreviations used are: MU-NeuAc, 4-methylumbelliferyl
-NeuAc; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-pro-
panesulfonic acid; GST, glutathione S-transferase; PBS, phosphate-
buffered saline; MES, 4-morpholineethanesulfonic acid; FPLC, fast pro-
tein liquid chromatography; 233SPG, 233 sialosylparagloboside;
CMC, critical micellar concentration; HPTLC, high performance thin
layer chromatography; GM2-AP, GM2 activator protein. The ganglio-
side nomenclature proposed by Svennerholm was followed (Svenner-
holm, L. (1980) Adv. Exp. Med. Biol. 125, 11). NEU is the official human
gene symbol approved by HUGO Gene Nomenclature Committee. In
order to avoid misinterpretation, the NEU symbol indicates the gene
product (i.e. sialidase); NEU2 is the symbol for cytosolic sialidase; the
two-letter code preceding NEU2 indicates the species of origin (e.g. Hs
indicates Homo sapiens).
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methanol (2:1, v/v), and a known volume of this solution, containing the
desired amount of ganglioside, was transferred into an Eppendorf tube,
the solvent being then completely removed by nitrogen fluxing. The
residue was kept for several hours under vacuum over P2O5 and then
dissolved with 60 l of redistilled water. The mixture was left to stand
overnight at room temperature before use (37). Mixed micelles of gan-
gliosides and detergent (Triton X-100) were prepared as follows. Deter-
gent (at millimolar concentrations) was dissolved in chloroform/meth-
anol (2:1, v/v), and a known volume of this solution was pipetted into an
Eppendorf tube and mixed with a sample of the starting ganglioside
solution in order to have the desired proportion of the two components.
The solvent was completely removed by nitrogen fluxing, and the re-
sulting residue was further dried, dissolved in 60 l of redistilled water,
and allowed to equilibrate at room temperature, as described above. At
the end, each mixture was buffered and used for sialidase assay in a
final volume of 100 l.
Preparation of Monomeric Dispersions of Gangliosides
Dispersions on Tube Walls
A known volume of ganglioside solution in n-propyl alcohol/water
(4:1, v/v), containing the desired amount (0.1–6.4 pmol) of 3H-labeled
GM2, GM1, or GD1a was transferred into an Eppendorf tube, and the
solvent was completely removed by nitrogen fluxing. The residue was
kept for several hours under vacuum over P2O5 and then dissolved with
60 l of redistilled water and allowed to equilibrate at room tempera-
ture. At the end, the mixture was buffered and used for sialidase assays,
in a final volume of 100 l. Under these conditions, the ganglioside
molecules are known (36) to adhere, at least partially, to the tube
surface. In order to establish the distribution of ganglioside, as well as
the sialidase reaction product(s), between the aqueous solution and the
tube surface, the aqueous assay mixture (before and after incubation
with sialidase) was transferred with a Pasteur pipette into a tube, the
pipette being washed several times with methanol, and the washings
were added to the pipetted incubation mixture. The resulting mixture,
containing the glycolipid in free solution, was frozen and lyophilized.
The residue was resuspended with 5 ml of emulsifier (Ultima Gold;
Packard), and the radioactivity was determined with a liquid scintilla-
tion counter (Packard Tri-Carb 460). The starting Eppendorf tube,
carrying the wall-bound ganglioside, was added with 0.1 ml of chloro-
form/methanol (2:1, v/v) and mixed, and the radioactivity was measured
as described above.
The conditions providing passage of monomeric dispersions of glyco-
lipid from the tube wall to the aqueous medium were worked out with
preliminary experiments using [Sph-3H]GM1 and Triton X-100. The
experimental approaches were as follows. (i) 0.1–2 pmol of [Sph-
3H]GM1 in n-propyl alcohol/water (2:1, v/v) and different amounts of
Triton X-100 (0.4–40 nmol) in chloroform/methanol (2:1, v/v) were
transferred into an Eppendorf tube, and the solvent was completely
removed by nitrogen fluxing. The resulting residue was kept for several
hours under vacuum over P2O5 and finally dissolved with 60 l of
redistilled water and allowed to equilibrate at room temperature. The
mixture was then added with buffer (at the optimal sialidase pH 5.6 or
at pH 7.0) and enzyme (final volume 100 l) and used for sialidase
assays. The distribution of GM1 and sialidase reaction product in the
aqueous solution and tube wall was determined as described above. (ii)
40 nmol of Triton X-100 in chloroform/methanol (2:1, v/v) and different
amounts of [Sph-3H]GM1 (0.9–83 pmol) in n-propyl alcohol/water (4:1,
v/v) were transferred in an Eppendorf tube, and the solvent was com-
pletely removed by nitrogen fluxing; the successive procedural steps
were the same as described above.
Dispersions on the Surface of Triton X-100 Micelles
On the basis of the indications provided by the experimental ap-
proaches described above, complete dispersion of [Sph-3H]GM1 on the
surface of Triton X-100 micelles was obtained mixing radiolabeled GM1
and Triton X-100 in a molar ratio of 1:2000. On this basis, the proper
amount of [Sph-3H]GM1 in n-propyl alcohol/water (4:1, v/v) and a
2000-fold (in molar terms) amount of Triton X-100 in chloroform/meth-
anol (2:1, v/v) were pipetted into an Eppendorf tube, and the solvent
was completely removed by nitrogen fluxing; the subsequent steps were
the same described above.
Sialidase Assay
The activity of HsNEU2 sialidase was determined essentially as
described by Venerando et al. (38). The reaction mixtures contained the
established amounts of HsNEU2 and substrate (see below), 50 mM
sodium citrate/phosphate buffer at the optimum pH (established to be
5.6 and at pH 7.0) in a final volume of 100 l. The control mixtures
(blanks) were carried out using heat-inactivated (5 min in boiling wa-
ter) recombinant HsNEU2. Km and apparent Vmax values were deter-
mined by the method of Lineweaver and Burk. The sialidase activity
was expressed as IU (mol of liberated NeuAc/min at 37 °C). The
results are always the means of two or three separate experiments
carried out in triplicate. The influence on sialidase activity of the
following detergents was studied: Triton X-100, CHAPS, octyl gluco-
side, and sodium deoxycholate. The following assay methods were
employed.
Fluorimetric Method
The reaction mixtures (100 l) set up with an appropriate concen-
tration of MU-NeuAc, in the presence or absence of 20 g of bovine
serum albumin and of different amounts of a detergent (when used)
were incubated at 37 °C with recombinant HsNEU2 (0.02 g at pH 5.6;
0.15 g at pH 7.0) for 10 min (pH 5.6) or 20 min (pH 7.0). Reactions were
stopped by the addition of 1.5 ml of 0.2 M glycine/NaOH, pH 10.2.
Fluorescence emission was measured on a Jasco FP-770 fluorometer
with excitation at 365 nm and emission at 445 nm, using 4-methylum-
belliferone to set up a calibration curve. A fluorescence of 0.100 corre-
sponded to 0.16 nmol of released 4-methylumbelliferone.
Colorimetric Method
The reaction mixtures (100 l) were set up with appropriate concen-
trations of 233 (or 236) sialyllactose, colominic acid, sialoglycopro-
tein (human fetuin, human 1-acid glycoprotein, human transferrin,
and mucin from bovine submaxillary glands), or gangliosides
233SPG, GD1b, and GT1b (the ganglioside concentration was in the
millimolar range). After incubation at 37 °C with recombinant HsNEU2
(0.2 g at pH 5.6; 1.5 g at pH 7.0) up to 90 min (depending on the
substrate), released sialic acid was measured by the chromatographic
microprocedure of Caimi et al. (39).
Radiochemical Methods
Ganglioside Substrates Used as Micellar Aggregates—The incubation
mixtures (100 l), containing different concentrations (in the millimolar
range) of micellar 3H-labeled ganglioside GM1, GM2, or GD1a or vesic-
ular GM3 (each carrying 0.15 Ci of radioactivity) and in the presence
or absence of different amounts of detergent, were incubated at 37 °C
with recombinant HsNEU2 (0.02 g at pH 5.6; 0.15 g at pH 7.0) for up
to 10 min (pH 5.6) or 30 min (pH 7.0) or up to 60 min in the case of GM1
and GM2. The incubations were terminated by cooling the tubes in an
ice bath, adding 400 l of tetrahydrofuran and careful vortexing. The
mixtures were then centrifuged at 10,000  g for 5 min, and 5 l of the
resulting supernatants were subjected to HPTLC on silica gel plates
with chloroform, methanol, 0.2% aqueous CaCl2 (50:42:11, v/v/v) as a
solvent system to separate the reaction products from the substrates.
The separated glycolipids were quantified by radiochromatoscanning
(Beta Imager 2000, equipped with the software interface Beta Vision,
Dell Optiplex Systems, Biospace Mesures, Paris, France), and the en-
zyme activity was calculated as described (38).
Monomeric Dispersions of Gangliosides as Substrates—The assay of
sialidase activity on monomeric dispersions of 3H-labeled gangliosides
(GM1 in most experiments; GD1a and GM2 in some experiments) was
carried out as follows. The incubation mixtures (100 l) set up in
Eppendorf tubes and containing monomeric dispersions of ganglioside
(concentration from 1.0  109 to 2  108 M) and 0.2 g (at pH 5.6) or
1.5 g (pH 7.0) of recombinant HsNEU2 were placed in an incubator
shaker and incubated at 37 °C for the established time (usually 10 min).
The enzyme reaction was stopped by immersing the tubes in an acetone/
solid CO2 bath and immediately freeze-dried. When different microbial
sialidases were employed, the same amount of enzyme (0.2 g) was
incubated in the presence of 4  109 M 3H-labeled GM1 for a proper
period of time at the optimal pH described for the single bacterial
sialidase.
The identification and quantification of the product of GM1 enzy-
matic hydrolysis were carried out by the already described HPTLC and
column chromatography procedures. In the case of the HPTLC method,
the freeze-dried residues were dissolved in 50 l of chloroform/methanol
(2:1, v/v), and the product of GM1 enzymatic hydrolysis was separated
by HPTLC, quantified by radiochromatoscanning, and used to deter-
mine the total enzyme activity. The identification of the reaction prod-
uct was performed by co-chromatography with standard 3H-labeled
GA1. In the case of the chromatographic method, the freeze-dried res-
idues were dissolved with 100 l of distilled methanol and quantita-
tively transferred upon DEAE-Sephadex A-25 columns (200 l of swol-
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len resin embedded in a 0.5  1.0-cm column) equilibrated in the same
solvent. Separation of GA1 and GM1 was obtained using sequentially
distilled methanol and 0.2 M sodium acetate in distilled methanol ac-
cording to Iwamori and Nagai (40). The fractions were concentrated,
and some aliquots were utilized to determine bound radioactivity in a
liquid scintillation counter, and other aliquots were submitted to
HPTLC in order to verify the efficacy of separation. The distribution of
sialidase activity between the aqueous solution and the tube wall was
established by separating the two fractions as described above and
measuring formed radiolabeled GA1 by the HPTLC method.
Other Chemical Methods
Protein content was determined by the Coomassie Brilliant Blue
method (41). Ganglioside-bound NeuAc was determined by the method
of Svennerholm (22).
RESULTS
Expression and Purification of HsNEU2 in E. coli Cells—In
order to facilitate the characterization of this human recombi-
nant enzyme, we expressed it in E. coli, using the pGEX-2T
vector (15) that provides HsNEU2 expression as a fusion pro-
tein with GST. HsNEU2 expression was easily detected on
crude E. coli extracts, due to the lack of endogenous sialidase
activity in these cells and the full conservation of catalytic
power by the protein chimera GST-HsNEU2, which was also
shown to exhibit a high degree of thermal stability. The fusion
protein was purified from a crude bacterial lysate by affinity
chromatography with GSH-Sepharose 4B. Cleavage of HsNEU2
from GST was achieved directly on the column using thrombin,
whose recognition sequence is located immediately upstream of the
ATG of the sialidase protein. Released HsNEU2 was directly eluted
from the column with PBS and further purified by FPLC using
Mono Q and Mono S ion exchange columns (Fig. 1). As shown in
Fig. 2, the purified protein appeared as a single band on SDS-
PAGE, with an apparent molecular mass of about 42 kDa, and
exhibited a single band at pH 6.8 upon isoelectrofocusing, indicat-
ing a high degree of purity. The average recovery of recombinant
HsNEU2 sialidase was about 0.9 mg protein starting from 1 liter of
E. coli culture.
HsNEU2 Basic Biochemical Characterization
pH Optimum, Stability, and General Characteristics—The
experiments concerning this point were carried out using MU-
NeuAc as substrate. The purified recombinant HsNEU2 had a
pH optimum 5.6, with appreciable activities in the pH range
5.0–7.2 (Fig. 3A) and was unstable upon freezing at 20 °C
(50% loss after one cycle of freezing-thawing) and storage at
4 °C (50% loss after 24 h). Notably, the enzyme could be stored
in PBS at 80 °C in small aliquots and thawed just before use
without any significant loss of activity (assessed after 1 year).
All measurements were carried out in the presence of bovine
serum albumin (0.2 mg/ml), to overcome any possible enzyme
inhibition exerted by liberated sialic acid. At the optimal pH,
the enzyme reaction occurred linearly with incubation time up
to 30 min and with the amount of protein up to 0.08 g (Fig. 3,
B and C). Na and K displayed slight activatory effects up to
105 M, Cu2 showed a strong inhibition over 105 M, and Ca2
showed no effect up to 103 M; all tested ions started inhibiting
in a more or less pronounced way over 103 M (Fig. 3D). The
enzyme kinetics obeyed regular Michaelis-Menten relation-
ships (see Fig. 4A). At the optimal pH, the Km and apparent
Vmax for MU-NeuAc were 0.44 mM and 47.6 IU/mg protein,
respectively (Table I). On this basis, routine determinations
were carried out using 0.01–0.02 g of enzyme protein, 500 M
MU-NeuAc, and a 10-min incubation. Ad hoc experiments
showed that the optimal pH (5.6) remained unchanged for all of
the other substrates tested. In the case of substrates like colo-
minic acid, glycoproteins, and oligosaccharides, where the en-
zyme activity detected was low or null, incubations were car-
ried out with enzyme quantity up to 5 g and incubation times
up to 90 min.
Substrate Specificity—Table I shows the different sialyl-gly-
coconjugates tested as substrates for recombinant HsNEU2
and the corresponding Km and apparent Vmax values, measured
after incubation at the optimal pH (5.6) and at pH 7.0. Hs-
NEU2 acted on 233 sialyllactose but not on the 236 isomer
nor on the 233 sialosyl linkage of the GM1 oligosaccharide,
even using long incubation times (90 min) and high enzyme
concentrations (5 g). The activity of HsNEU2 on sialoglyco-
proteins was generally low, with the exception of fetuin; the
apparent Vmax at pH 5.6 decreased from a maximum of 12.7
FIG. 1. Elution profile of recombinant HsNEU2 on Mono Q and
Mono S columns. A, 1 mg (as protein) of the HsNEU2 preparation,
obtained after GSH-Sepharose column chromatography and trombin
splitting of GST, was submitted to FPLC chromatography on a Mono Q
HR 5/5 column. B, the eluted fractions from the previous column car-
rying the enzyme, after dialysis and concentration under vacuum, were
applied to a MONO S HR 5/5 column. The assay of sialidase was
performed by the fluorimetric assay (substrate MU-NeuAc), and protein
was determined by measuring absorbance at 280 nm. Hatched line,
elution with 50 mM MES buffer, pH 6.7, carrying a linear NaCl gradient
from 0 (after 9 ml of elution) to 1 M (after 19 ml of elution). For details,
see “Experimental Procedures.”
FIG. 2. Analysis of purified HsNEU2, after Mono S HR 5/5 col-
umn chromatography. A, SDS-PAGE of the product obtained after
GSH-Sepharose column chromatography and trombin splitting of GST.
B, SDS-PAGE of the product after MONO S HR5/5 FPLC. C, isoelec-
trofocusing of the product after MONO S HR5/5 FPLC. For details, see
“Experimental Procedures.”
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IU/mg protein (fetuin) to a minimum of 0.7 IU/mg protein
(1-acid glycoprotein). The affinity for these substrates could
not be measured accurately due to the paucity of the enzyme
action. Since these glycoproteins contain 233 (fetuin), mixed
233 and 236 (1-acid glycoprotein), and 236 (transferrin)
sialosyl linkages (to galactose), the detected activity confirmed
the ability of HsNEU2 to hydrolyze 233 linked sialosyl resi-
dues in glycoproteins. However, the enzyme was also capable of
hydrolyzing the 236 sialosyl bond of transferrin, differently
from the 236 sialosyl linkage present in 236 sialyllactose.
The enzyme did not seemingly discriminate between N- and
O-glycosylated glycoproteins. Moreover, HsNEU2 did not
cleave at all the 238 sialosyl linkage present in colominic
acid. HsNEU2 removed with high efficiency sialic acid residues
from gangliosides GD1a, GT1b, 233SPG, and GD1b (produc-
ing GM1, GD1b, asialo-SPG, and GM1, respectively). At the
used concentrations (104 to 105 M), all of these gangliosides
were present as micelles. Instead, using the same concentra-
tions, the enzyme action on GM3 (vesicles) was extremely poor
and completely null on GM1 and GM2, which also occur as
micelles (see Table I).
The V/[S] curves (see examples in Fig. 4) obeyed typical
Michaelis-Menten kinetics. The calculated Km at the optimal
pH had similar values for GD1b and GT1b (0.59 and 0.62 
103 M), 233SPG (0.43  103 M), and GM3 (0.43  103 M)
but a higher value for GD1a (0.91  103 M). The apparent
Vmax value, always at the optimal pH, was the highest for
GD1a (250 IU/mg protein), followed by GT1b and 233SPG,
and the lowest for GM3 and GD1b (7.8 and 7.5 IU/mg protein,
respectively). This indicates that the enzyme prefers the 233-
linked sialic acid residues at the terminus of the ganglioside
oligosaccharide chain, although it is also able to hydrolyse the
238-linked sialic acid residues present in ganglioside GD1b.
The apparent Vmax of HsNEU2 on pure GM3 (which features a
vesicular type of aggregation) is low anyway (7.8 mg protein),
despite the presence of the 233 sialosyl linkage.
As shown in Table I, HsNEU2 expressed appreciable activity
at pH 7.0 with all tested substrates on which the enzyme was
capable of working. The ratio between the activity (Vmax) at the
optimal pH and pH 7.0, in the absence of detergents, ranged
from a minimum of 1.55 with 1-acid glycoprotein to a maxi-
mum of 24 with GD1a. With all substrates, the Km values were
practically identical at pH 5.6 and 7.0.
Effect of Detergents—The effect of neutral (Triton X-100 and
octyl glucoside) and ionic (sodium deoxycholate and CHAPS)
detergents on HsNEU2 activity was studied. None of these
detergents (up to 0.5% concentration) influenced the enzyme
activity on MU-NeuAc, sialyl-oligosaccharides, colominic acid,
and all the tested sialoglycoproteins. Conversely, remarkable
activatory effects were observed with gangliosidic substrates.
The highest activation (1.5–2.5-fold, depending on the gangli-
oside) was observed with Triton X-100 at the optimal 0.02%
(w/v) concentration, followed by octyl glucoside (1.3–2.2-fold at
0.08% w/v) and sodium deoxycholate (1.1–1.8-fold at 0.03%
w/v). The only exception was GD1b, where all detergents
caused a small decrease of the apparent Vmax.
The activity of HsNEU2 toward mixed micelles of ganglio-
side/Triton X-100 followed again regular Michaelis-Menten ki-
netics (see, for example, the case of GM3 (Fig. 4)). In any case,
the most striking effect of the detergent was detectable just on
ganglioside GM3, where the presence of Triton X-100 caused a
more than 8-fold increase of apparent Vmax. Moreover, the
presence of detergent increased the affinity, as compared with
homogeneous micelles. This increase was highest, about 6-fold,
with GD1a. Notably, none of the used detergents, in a wide
range of concentrations, enabled HsNEU2 to work on micellar
GM1 and GM2.
The effect of Triton X-100 was present also at pH 7.0. At this
pH, the increase of enzyme activity due to Triton X-100 was
markedly higher than at the optimal pH. In the case of GM3,
the activity increased 8.6-fold at pH 5.6 and 13.7-fold at pH 7.0,
and in that of GD1b, the detergent caused a substantial in-
FIG. 3. Basic properties of purified HsNEU2 ascertained using MU-NeuAc as substrate. A, effect of pH. Assay conditions were as follows:
0.02 g of enzyme; 0.5 mM substrate; incubation time, 10 min. B, effect of incubation time. Assay conditions were as follows: 0.02 g of enzyme;
0.5 mM substrate; pH 5.6; increasing incubation time. C, relationship between enzyme activity and enzyme content. Assay conditions were as
follows: 0.5 mM substrate; pH 5.6; increasing amounts of enzyme; incubation time, 10 min. D, effect of Cu2, Na, K, Ca2, Mg2, and Fe2. Assay
conditions were as follows: 0.02 g of enzyme; 0.5 mM substrate; pH 5.6; incubation time, 10 min; ions at different concentrations. For further
details, see “Experimental Procedures.” The data shown are the average of three experiments carried out in triplicate.
HsNEU2 Hydrolysis of Monomerically Dispersed GM1 Ganglioside 3173
 at BIBL D
ELLA FAC DI M
ED, on April 26, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
crease (2.7-fold) against an almost 30% decrease at pH 5.6.
Also, in the presence of detergent, the Km values did not un-
dergo significant changes from pH 5.6 to 7.0.
HsNEU2 Activity toward Monomeric Dispersions of
GD1a and GM1 Gangliosides
After having established the ability of recombinant HsNEU2
to hydrolyze micellar gangliosides, particularly GD1a (that can
be radiolabeled with high specific radioactivity), we performed
experiments aimed at ascertaining the possible action of the
enzyme on the monomeric form of GD1a that is at concentrations
below 108 M. For this purpose, we used the radiochemical assay
method, the only method possessing adequate sensitivity. As
shown in Fig. 5, GM1 was formed as the principal reaction
product in a time-dependent manner, indicating the ability of
HsNEU2 to hydrolyze monomeric GD1a. However, the same
experiments showed the formation of an additional radioactive
compound with a slightly higher RF than GM1 in our HPTLC
separation system. This compound exhibited the same Rf of
standard asialo-GM1 (GA1) (Fig. 5), and its identification as GA1
was accomplished using both HPTLC co-migration experiments
and ion exchange chromatography on DEAE-Sephadex A25,
which differentiates the sialylated and not sialylated glycolipid.
Notably, also at pH 7.0 (Fig. 5), HsNEU2 was able to catalyze the
hydrolysis of GD1a into GM1 and of formed GM1 into GA1.
Subsequent studies performed at nanomolar concentrations of
[3H]GM1 at the optimal pH (see Fig. 6) showed that the forma-
tion of GA1 from monomeric GM1 was time- and enzyme concen-
tration-dependent. At this point, a consideration had to be made.
Since, at the used concentrations, the ganglioside is present in
the monomeric form and since monomeric gangliosides are
known to adhere to the wall of the test tube, the distribution of
the GM1 substrate as well as of the GA1 reaction product be-
tween the aqueous solution and the tube wall had to be investi-
gated. The results are shown in Table II. Before incubation with
HsNEU2, GM1-bound radioactivity was almost completely
linked to the tube wall, an almost negligible portion being meas-
urable in the water solution. After incubation, 97.5% of total
radioactivity was again linked to the tube wall, and 1.8% was in
the water solution. The distribution of GM1 and formed GA1 into
the two fractions was parallel, and the sialidase activity was
measurable only on the tube wall, with a recovery of 95.7%,
indicating that the enzyme acted on tube wall-linked GM1, and
the formed GA1 remained linked to the tube wall. Surprisingly,
despite the very low substrate concentration, the V/[S] curve
seemingly showed a hyperbolic course, and the apparent Vmax
and Km values could be determined with an acceptable degree of
approximation: about 10  109 M and 25 IU/mg protein, re-
spectively (Fig. 7A). Moreover, pilot experiments showed that
HsNEU2 was able to affect [Sph-3H]GM2 at 2–5 nM concentra-
tions with formation of a compound migrating a little faster than
GM2 and lacking the acidic charge, presumably asialo-GM2.
Hydrolysis of Monomerically Dispersed GM1 in
Triton X-100 Micelles
The capability of Triton X-100 (CMC about 104 M) to pro-
mote the passage of monomerically dispersed GM1 from the
reaction tube walls to the aqueous solution was ascertained. As
shown in Table III, using a fixed amount of radioactive GM1 (1
nM) and increasing amounts of Triton X-100 (from 3.9 to 396
M), a progressive passage of the ganglioside into the aqueous
phase was observed. Actually, using 396 M detergent (i.e.
about 0.4 mM), 97% of the total radiolabeled GM1 was recov-
ered in the aqueous solution, and only 1.7% bound to the tube
wall. On the other hand, maintaining constant detergent con-
centrations (0.4 mM) and increasing the quantity of radioactive
GM1 from 1.0 to 40.2 nM (Table III, bottom), almost all of the
ganglioside (about 97%) remained in the aqueous phase. Fi-
nally, as shown in Table IV, the sialidase activity on GM1,
which was almost completely (95.7%) linked to the tube wall in
the absence of Triton X-100, moved to the aqueous solution
with increasing amounts of added detergent reaching 97.5% at
0.4 mM detergent concentration. Using monomeric dispersions
of GM1 on the surface of Triton X-100 micelles (GM1/Triton
X-100 molar ratio, 1:2000) the V/[S] relationships obeyed typ-
ical Michaelis-Menten kinetics, with Km and Vmax values of 15
nM and 72 IU/mg protein, respectively (see Fig. 7B). The data
shown in Fig. 7, A and B, show that the kinetics of HsNEU2 on
monomerically dispersed GM1, on the tube wall or on the
surface of Triton X-100 micelles, had the same trends at pH 5.6
and 7.0. The apparent Vmax value was obviously lower at pH
7.0 than 5.6 (25 versus 72 IU/mg protein), whereas the Km
values were identical.
Action of Various Microbial Sialidases on GM1 Monomeric
Dispersions: Comparison with HsNEU2—As shown in Fig. 8,
the activity on monomeric dispersions of [3H]GM1 also was
displayed by some microbial sialidases. In fact, using the same
incubation conditions as for the HsNEU2 assay (4 nM [3H]GM1,
0.2 g of enzyme, 10-min incubation at 37 °C, pH 5.6) and the
FIG. 4. Kinetics of HsNEU2 on various substrates (MU-NeuAc,
233 sialyllactose, and GM3). Assay conditions were as follows: 0.02
g of enzyme; pH optimum, 5.6; incubation time, 10 min; Triton X-100
(when present), 0.4 mM. The enzyme activity was measured by the
fluorimetric method with MU-NeuAc, by the colorimetric method with
233 sialyllactose, and by the radiometric method with GM3. The data
shown are the average of two experiments carried out in triplicate.
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pH reported to be optimal for the individual bacterial sialidases
(5.5 for V. cholerae sialidase; 5.6 for the remaining ones), for-
mation of radiolabeled GA1 was observed in the case of A. urea-
faciens and C. perfringens sialidases. The activities of these
enzymes corresponded to about 48 and 3.8% of that displayed
by HsNEU2, respectively. No activity at all on monomeric GM1
was detectable with S. typhimurium and V. cholerae sialidases.
DISCUSSION
The mammalian sialidases so far cloned (9, 10) show remark-
ably similar amino acid sequences and a highly conserved
active site. However, they have different biological origin and
subcellular localization, display different biological implica-
tions, and exhibit different substrate specificities. The molecu-
lar features responsible for these behavioral differences are
unknown. The first aim of the present investigation was to
better understand the sialidase specificity toward gangliosides,
natural substrates of amphiphilic nature, in comparison with
companion sialoglycoproteins and sialooligosaccharides. The
particular attention to gangliosides had the following grounds:
(i) gangliosides show characteristic aggregation properties in
aqueous media, since they undergo monomer to micellar tran-
sition at very low critical micellar concentrations, 108 to 107
M, with the exception of GM3, which adopts a vesicular form of
aggregation; (ii) they occur in membranes either in a packed
organization (lipid rafts) (20, 21), resembling a micellar orga-
nization or in molecular dispersion as monomers; and (iii) they
are involved in important events of social cell behavior, like
cell-cell interactions, receptor regulation, and transmembrane
signaling (42, 43), where their molecular and supramolecular
features may play a crucial role. For the first time, the recom-
binant human cytosolic sialidase HsNEU2 was employed as a
model enzyme.
HsNEU2 was expressed in E. coli cells as a protein chimera
with GST with the advantage of grossly purifying it by column
affinity chromatography on GSH-Sepharose, using GST as the
binding portion, and of having an active and stable sialidase.
After two additional chromatographic passages on FPLC, with
concomitant detachment of GST by trombin treatment, the
enzyme was homogeneous although thermolabile (unless
stored at 80 °C). The pH optimum was confirmed to be 5.6 on
all of the used substrates, as already reported for HsNEU2-
transfected cells (15), the V/E and V/t relationships had the
expected features, and the V/[S] relationships obeyed Michae-
lis-Menten kinetics. The detailed study on the enzyme sub-
TABLE I
Kinetics parameters of HsNEU2 action on different substrates
Assay conditions were as follows: sialidase assay mixture, 50 mM sodium citrate-phosphate buffer; substrate at saturating concentrations; 0.02
g of enzyme at pH 5.6 (established to be the optimal pH) and 0.15 g at pH 7.0; incubation time at 37 °C up to 30 min depending on the substrate
and pH (for more details, see ‘‘Experimental Procedures’’). In the case of GM1, GM2, colominic acid, 236 sialyllactose, and GM1 oligosaccharide,
different substrate concentrations were used as well as enzyme amounts up to 5 g and incubation times up to 90 min. Sialidase activity on GM1,
GM2, GM3, and GD1a was assayed by the radiochemical assay; activity on GD1b, GT1b, and 233SPG was assayed by the colorimetric assay; and
that on MU-NEUAc was assayed by the fluorometric assay.
Substrate Triton X-100 (0.02%, w/v)
Vmax
Km (10
3
M)a
pH 5.6 pH 7.0
IU/mg of protein
Gangliosides
GM3  7.80 2.23 0.40
 67.00 30.70 0.24
GD1a  250.00 10.41 0.91
 322.00 22.50 0.14
GD1b  7.50 0.80 0.59
 5.45 2.20 0.51
GT1b  133.00 17.50 0.62
 190.00 27.20 0.38
233SPG  105.00 12.22 0.43
 253.00 29.12 0.28
GM1  NDb ND ND
 ND ND ND
GM2  ND ND ND
 ND ND ND
Glycoproteins
Fetuin No effectc 12.70 3.40 Not establishedd
Transferrin No effect 0.75 0.40 Not established
1-acid glycoprotein No effect 0.70 0.45 Not established
Mucine No effect 1.82 0.17
Colominic acid No effect ND ND ND
Oligosaccharides
233 sialyllactose No effect 10.00 2.12 0.31
236 sialyllactose No effect ND ND ND
GM1-oligosaccharide No effect ND ND ND
Artificial substrate
MU-NeuAc No effect 47.60 14.17 0.44
a No variations were detectable between acidic and neutral pH values.
b ND, not detectable.
c No effect, no effect by Triton X-100 was observed.
d Not established, it could not be established in an accurate way.
e From bovine submaxillary glands.
FIG. 5. HsNEU2 activity on monomeric dispersions of [Sph-
3H]GD1a. Enzyme assay conditions, at 37 °C, were as follows: 2 nM
[Sph-3H]GD1a; 0.2 g of enzyme and 10–30-min incubation at pH 5.6;
1.2 g of enzyme and 30-min incubation at pH 7.0. Lane 1, blank
mixture (without enzyme); lanes 2 and 3, mixture incubated at pH 5.6
(10 and 30 min, respectively); lane 4, mixture incubated at pH 7.0; lane
5, standard [Sph-3H]GD1a; lane 6, standard [Sph-3H]GM1; lane 7,
standard [Sph-3H]GA1.
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strate specificity provided some novel pieces of information.
The first message concerned the linkage specificity, namely the
sialosyl linkages 233 and 236 to galactose and 238 to a
further sialic acid residue. The highest activity and affinity
were observed on the 233 linkage-containing glycoconju-
gates, followed by 238 and 236 linkages, although with
some relevant exceptions. In fact, the 233 linkage present in
the GM1 oligosaccharide and in micellar GM1 and GM2 was
resistant to the enzyme action as well as the 238 linkage
present in colominic acid and the 236 linkage present in
236 sialyllactose. This means that a portion of the substrate
molecule other than the sialosyl residue plays an important
role in catalysis, suggesting the presence in HsNEU2 of addi-
tional sites (peptide domains or single amino acid residues
sterically vicinal to the active site) involved in substrate recog-
nition. The second message concerned the effect on the enzyme
action of neutral and ionic detergents, the most active being
Triton X-100. The detergent effect was observed only on gan-
glioside substrates, indicating its action at the substrate, not
enzyme, level. At the optimal pH, and using millimolar gangli-
oside concentrations, largely above the CMC, hence in their
micellar form, the detergent effect consisted in an increase of
apparent Vmax (1.7-fold in the case of GD1a, where the activa-
tory effect was the highest) and decrease of Km (the highest
decrease, about 6.5-fold, again on GD1a). GD1b was the only
ganglioside where the effect of detergent was almost null. In-
stead, GM3 showed the highest change in apparent Vmax (8.5-
fold rise), in the presence of detergent very likely due to its
transition from the vesicular form of aggregation to the (mixed)
micellar one with Triton X-100. Remarkably, the micelles of
GM1 and GM2 were completely resistant to HsNEU2 action,
regardless of the presence or absence of detergents. As a whole,
these data are consistent with the notion that HsNEU2 is
capable of recognizing not only the type of sialosyl linkage and
the aglycone part of the molecule, but also the supramolecular
organization (micelles and vesicles) of sialoglycoconjugates of
an amphiphilic nature.
The third novel aspect of HsNEU2 is its peculiar ability to
remove sialic acid from gangliosides in the concentration range
109 to 108 M, which is their monomeric form. This was
observed with GD1a but also, and particularly, with GM1,
which was studied in detail, and GM2. The very important
difference was that in the case of GD1a, the enzyme works also
on the micellar aggregation, whereas with GM1 and GM2 it
absolutely does not. It should be recalled that at very low
concentrations, the ganglioside substrate is not free in the
aqueous reaction mixture but bound to the test tube wall.
Despite this, recombinant HsNEU2 affects GM1 with the ex-
pected dependence on time and enzyme amount and with a
V/[S] curve obeying Michaelis-Menten kinetics. The apparent
Vmax was 25 IU/mg protein, and the Km was as low as 10 nM,
which is quite surprising for an enzyme. Moreover, the enzyme
activity on monomeric dispersions of GM1 occurs also in the
presence of Triton X-100. In this case, detergent addition leads
to complete “solubilization” (detachment from the tube wall) of
the monomeric GM1, probably because ganglioside is incorpo-
rated into the surface of Triton X-100 micelles, which are
soluble. It seems reasonable to suggest that recombinant Hs-
NEU2 is able to recognize ganglioside molecules dispersed on
surfaces. Using Triton X-100/GM1 micelles with a molar ratio
of 2000:1, which is a very dispersed form of GM1, the apparent
Km was still very low (15 nM) and Vmax was raised to 72 IU/mg
protein.
A further aim of the investigation was to quantify the capa-
bility of HsNEU2 to work at a neutral pH. It was surprising to
observe that the enzyme displayed, on all tested substrates and
in the absence of Triton X-100 a substantial activity at pH 7.0,
ranging (with reference with that at pH 5.6) from a minimum
of 4% with GD1a to a maximum of 64% with 1-acid glycopro-
tein. Using ganglioside substrates, in the presence of Triton
X-100, the activatory effect of detergent tended to be relatively
more effective at pH 7.0 than 5.6. In fact, the percentage of
activity in reference to that at the optimal pH, rose from 4 to 7%
with GD1a, from 28 to 45% with GM3, and from 10.7 to 40.3%
with GD1b. The Km values were in all cases identical at two pH
values, indicating that the affinity of the enzyme was not
affected by pH within the range used. Notably, also the ability
of the enzyme to recognize monomeric dispersions of ganglio-
side substrates and to affect monomeric dispersions but not
micellar aggregations of GM1 was expressed also at 7.0, with
constant Km and a 30–40% decrease of apparent Vmax.
The accessibility or inaccessibility of the sialic acid of GM1
(and GM2) to sialidase action is an old and controversial issue.
The lack of accessibility exhibited by some bacterial (V. chol-
erae), viral (influenza virus), and mammalian sialidases (1) was
assumed to derive from a steric hindrance by the vicinal N-
acetylhexosamine residue preventing the enzyme from prop-
erly interacting with the substrate (44). In other words, the
constraint was viewed as residing at the substrate level. How-
ever, other sialidases of bacterial and mammalian origin re-
sulted in the ability to promote sialic acid removal from GM1
and GM2 (45–49), pointing to structural features at the en-
zyme level. Notably, Wang et al. (50) showed that proper point
mutations on recombinant rat plasma membrane-bound siali-
dase markedly enhanced the ability of the enzyme to hydrolyze
GM2. An important contribution to clarify the issue comes from
FIG. 6. Effect of incubation time and enzyme content on Hs
NEU2 action on monomeric dispersions of GM1. A, effect of incu-
bation time. Assay conditions were as follows: 0.2 g of enzyme; 1 nM
[Sph-3H]GM1; pH 5.6, 37 °C. B, relationship between enzyme activity
and enzyme content. Assay conditions were as follows: 1 nM [Sph-
3H]GM1; pH 5.6, 37 °C; incubation time, 20 min. The data shown are
the average of two experiments carried out in triplicate.
HsNEU2 Hydrolysis of Monomerically Dispersed GM1 Ganglioside3176
 at BIBL D
ELLA FAC DI M
ED, on April 26, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
the reported resolution of the three-dimensional structure of
human GM2 activator protein (GM2-AP) (51). This protein is a
cofactor in the intralysosomal degradation of gangliosides, and
its genetically determined defect leads to a variant of Tay-
Sachs disease known as AB GM2 gangliosidosis (52). The
GM2-AP crystal structure reveals a -cup-shaped folding, with
a central hydrophobic cavity, which is suitable for binding the
ceramide lipid tail of gangliosides, namely GM2. The activator
protein probably extracts single ganglioside molecules from the
membrane and confers on the head saccharide moiety a new
conformation that renders it accessible to the enzyme, in this
case a -N-acetylhexosaminidase. This model can be applied
also to the GM1/GM2 sialidase interactions. Actually, in a
recent study, mouse plasma membrane-associated sialidase
(MmNEU3) was shown to remove sialic acid from GM1 and
GM2 in the presence of GM2-AP but also, although with a
much lower efficiency, in the absence of the activator (49). A
possible explanation for all of these different behaviors is that
the oligosaccharide portion of gangliosides, like GM1 and GM2,
should have a particular conformation relative to the hydro-
phobic tail, in order to be recognized and hydrolyzed by siali-
dase. This conformation can simply be met by ganglioside mol-
ecules dispersed on a surface (as in the case of recombinant
HsNEU2) or by ganglioside molecules inserted into the hydro-
phobic cavity of GM2-AP. For the case where sialidases seem-
ingly act on GM1 and GM2 micelles, the hypothesis can be put
forward that the right substrate conformation is obtained
through a preliminary interaction of the substrate with a bind-
ing site of the enzyme itself acting somewhat like the GM2-AP.
The availability of different recombinant sialidases, properly
engineered by selected point mutations, might contribute to
verify this line of interpretation.
The importance of structural differences among sialidases,
especially with regard to substrate specificity and kinetics pa-
rameters, is also stressed by differences in the action of recom-
binant HsNEU2 and the other mammalian cytosolic sialidases
purified from rat liver (53) and Chinese hamster ovary cells
(54). For instance, the latter enzymes, differently from Hs-
NEU2, have a pH optimum of 6.0, recognize as substrates
236 sialyllactose and colominic acid, and display a higher
activity on transferrin than fetuin and a relatively lower activ-
ity on (micellar) gangliosides. Instead, they share with Hs-
NEU2 the inability to hydrolyze micellar GM1 and GM2. It is
unknown whether these sialidases are able to affect ganglio-
sides as monomeric dispersion. The reason for all of these
differences may reside in structural differences or, in some
cases, the different analytical procedures employed or seem-
ingly because the issue (it is the case of ganglioside monomeric
dispersions) was not addressed.
Finally, the possible link between the results provided by
this study and the possible physiological significance of cytoso-
lic sialidases in mammalian cells deserves comment. Transfec-
tion of rat B16 melanoma cells with rat NEU2 cDNA was
reported (55) to suppress pulmonary metastases, and the met-
TABLE II
Action of HsNEU2 on monomeric dispersions of 3H-labeled GM1: Evidence for the enzyme activity on tube wall-bound gangliosides
Assay conditions were as follows: HsNEU2, 0.4 g; 1 nM Sph-3HGM1; 50 mM citrate/phosphate buffer, pH 5.6; 30 min at 37 °C. Separation of
GM1 (and GA1, after incubation) between the tube wall-bound form and the form present in the aqueous solution was performed as described under
‘‘Experimental Procedures.’’ The data are the means  S.D. of three experiments carried out in triplicate. The same radioactivity distribution
pattern was observed at pH 7.0, using 1.2 g of enzyme.
Before incubation After incubation
Total
radioactivity Percentage
Total
radioactivity Percentage Sialidase activity Percentage
dpm % dpm % IU/mg of protein %
Aqueous solution 53  3 1.7 58.4  4 1.83 NDa
Test tube wall 3120  240 98.1 3100  280 97.5 1.31  0.09 95.7
Total 3180  159 100 3180  159 100 1.37  0.07 100
Recovery (%) 99.8 99.33 95.7
a Not detectable.
FIG. 7. Kinetics of HsNEU2 on mo-
nomeric dispersions of GM1 in the
absence of Triton X-100 (dispersion
on the tube wall) (A) or presence of
Triton X-100 (dispersion on the deter-
gent micelle) (B). Enzyme assay condi-
tions were as follows: 0.4 mM Triton
X-100, when present; [Sph-3H]GM1 at
different concentrations; 0.2 g of enzyme
and 10 min incubation at pH 5.6; 1.2 g
enzyme and 30 min incubation at pH 7.0.
The data shown are the average of two
experiments carried out in triplicate. ,
pH 5.6; Œ, pH 7.0.
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astatic potential of sublines of mouse colon adenocarcinoma
was inversely proportional to the level of endogenous NEU2
(56). On the other hand, transfection of human epidermoid
carcinoma cells with hamster NEU2 matched with enhance-
ment of epidermal growth factor receptor activity (57) and
overexpression of rat NEU2 in rat myoblasts led to promotion
of differentiation toward myotubules (58). Taken together,
these data indicate that whenever an increase or appearance of
NEU2 activity was observed, a decrease of GM3 and an in-
crease (or appearance) of lactosylceramide, the product of GM3
desialosylation, were detected. Since both GM3 and lactosyl-
ceramide are involved in transmembrane signaling pathways
(59), generally with opposite biological effects, a role of siali-
dase as a regulatory switch can be easily suggested. The fact
that HsNEU2 displays activity also at a neutral pH removes, at
least in part, the objection of what can be the physiological role
of a cytosolic enzyme having an optimal pH in the acidic range.
Instead, it can be suggested that a transient acidification of a
microenvironment of the cytosol may constitute an efficient
mechanism of in vivo enzyme regulation.
Assuming gangliosides as a main target for cytosolic siali-
dase and considering that the assumed intracellular localiza-
tion of gangliosides is to the external surface of the plasma
membrane or the luminal surface of Golgi membrane, the prob-
lem of substrate accessibility to the enzyme is pivotal. The
possibility that under proper conditions the cytosolic enzyme
can leave its residential compartment and reach ganglioside
cannot be excluded. In fact, it was shown (60, 61) that in human
cultured fibroblasts and Chinese hamster ovary cells, NEU2
could be released in the medium and reach surface-linked
ganglioside. Moreover, small amounts of gangliosides are asso-
ciated with intermediate filaments and microtubes (62) or are
present in the cytosol in the form of protein complexes (63) and,
as such, can be reached by the cytosolic sialidase. At this level,
the ability of the enzyme to act on either monomerically dis-
persed or “clustered” gangliosides, although with quite differ-
ent affinity and efficiency, might be critical for the dynamics
TABLE III
Triton X-100 mediates the passage of monomeric dispersions of GM1 from the test tube wall to the aqueous medium
Experimental conditions were as follows. Top, Sph-3HGM1, 1 nM; Triton X-100, from 0 to 396 M; 50 mM sodium citrate phosphate buffer, pH
5.6; final volume, 0.1 ml; 37 °C. Bottom, Sph-3HGM1, from 1 to 40.2 nM; Triton X-100, 396 M; 50 mM sodium citrate/phosphate buffer at pH 5.6;
final volume, 0.1 ml; 37 °C. The mixtures were prepared, and the distribution of GM1 molecules between the Eppendorf test tube wall and the
aqueous solution was determined as described under ‘‘Experimental Procedures.’’ The data shown are the mean values  S.D. of three experiments
carried out in triplicate. No cold GM1 was used. Starting GM1-bound radioactivity was 3180 dpm. No significant difference in the distribution of
radioactivity into the test tube wall and aqueous solution was observed at pH 7.0.
Triton X-100
GM1-bound radioactivity
Aqueous solution Test tube wall
Radioactivity Percentage Radioactivity Percentage
M total dpm % total dpm %
0 53  3 1.7 3120  159 98.1
3.9 700  45 22.0 2400  122 75.5
33.0 1220  72 38.4 1900  101 59.7
99.0 1890  98 59.4 1050  55 33.0
198.0 2660  130 83.6 480  22 15.1
297.0 3010  138 94.6 80  5 2.5
396.0 3090  141 91.2 50  2 1.6
GM1 GM1-bound radioactivity
Concentration Radioactivity
Aqueous solution Test tube wall
Radioactivity Percentage Radioactivity Percentage
nM total dpm total dpm % total dpm %
1.0 3180 3090  141 97.2 50  2 1.6
1.3 4134 4304  122 97.4 58  3 1.4
5.05 16,059 15,593  855 97.1 321  18 2.0
9.02 28,684 27,709  1434 96.6 946  51 3.3
19.7 62,646 60,641  3217 96.8 1940  142 3.1
40.2 127,836 123,617  5870 96.7 3068  153 2.4
TABLE IV
Action of HsNEU2 on monomeric dispersions of GM1: Effect of
Triton X-100-mediated passage of GM1 monomers from the test
tube wall to the aqueous solution
Experimental conditions were as follows: Sph-3HGM1, 1 nM; Triton
X-100, from 0 to 396 M; 50 mM citrate/phosphate buffer, pH 5.6;
HsNEU2, 0.4 g; final volume, 0.1 ml; incubation time, 10 min at 37 °C;
separation of formed Sph-3HGM1 by HPTLC; radioactivity measure-
ment by radiochromato scanning. For details, see ‘‘Experimental Pro-
cedures.’’ The data shown are the mean values of two experiments
carried out in triplicate. Starting total sialidase activity was 0.55 nIU.
The same trend of enzyme activity distribution in the aqueous solution
and test tube wall was observed at pH 7.0 (1.2 g of enzyme).
Triton
X-100
Sialidase activity
Aqueous solution Test tube wall
Activity Percentage Activity Percentage
nM total nIU % total nIU %
0 NDa 0.526 95.7
3.9 0.124 22.5 0.412 74.9
33.0 0.209 38.1 0.331 60.2
99.0 0.330 60.1 0.171 32.4
198.0 0.457 83.1 0.086 15.7
297.0 0.522 94.9 0.012 2.2
396.0 0.543 97.7 ND
a ND, not detectable.
FIG. 8. Action of different sialidases on monomeric disper-
sions of [Sph-3H]GM1. Enzyme assay conditions were as follows: 0.2
g of enzyme; 1 nM [Sph-3H]GM1; incubation time, 10 min; optimal pH,
5.5 for V. cholerae sialidase and 5.6 for the remainder ones; 37 °C. Lane
1, blank (without enzyme); lane 2, with HsNEU2; lane 3, with
S. typhimurium sialidase; lane 4, with V. cholerae sialidase; lane 5, with
C. perfringens sialidase; lane 6, with A. ureafaciens sialidase; lane 7,
standard [Sph-3H]GM1; lane 8, standard [Sph-3H]GA1. When S. typhi-
murium and V. cholerae sialidase were employed, 1 g of enzyme was
added, and the incubation time was extended to 60 min.
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and function of lipid rafts. Of course, huge efforts must be made
to properly approach and make clear these important issues.
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